retatrutide success stories Transformative Weight Loss Journey with What Is the Success Rate

An Epic Research study found that two years after stopping GLP-1 medications, most patients sustained at least some weight loss

Phase 2 studies showed people losing up to 24% of their body weight over 48 weeks at the highest doses tested

GLP-1 patient trends: demographics and adherence patterns Usage across the population A nationally representative survey conducted by RAND found that 11.8% of Americans have used GLP-1 drugs for weight loss, and about 14% express interest, while 74% say they do not plan to take them

The current market is largely private via patients who are self-paying, he said

UNC Health

Flex Certification only applies to CGMP, Licensed 503B manufacturing facilities All compounds are not created equal vs Look for the FDA - NDC code & the Flex Certified Label 503A's are regulated by the state